Effect of the First-Line Therapy with Osimertinib for a Metastatic Choroidal Tumor in Advanced-Stage Lung Cancer: A Case Report

Although the advent of molecular-targeted drugs has improved the prognosis of various cancers, the long-term prognosis and side effects as the first-line therapy for metastatic choroidal tumors remain unclear. We describe a case in which the first-line therapy of osimertinib has shown long-term succ...

Descripción completa

Detalles Bibliográficos
Autores principales: Umeda, Ikuko, Kitamura, Yuta, Yokouchi, Hirotaka, Baba, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368102/
https://www.ncbi.nlm.nih.gov/pubmed/37496595
http://dx.doi.org/10.1159/000531255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368102/
https://www.ncbi.nlm.nih.gov/pubmed/37496595
http://dx.doi.org/10.1159/000531255

Ejemplares similares